Our findings reported here support the hypothesis that PSD95/nNOS interaction in the amygdala is a key step in fear memory formation and may represent a novel treatment target with a minimal adverse effect profile for fear-related disorders, such as PTSD. This evidence concerns the gene NOS1 and post-traumatic stress disorder.